DexCom (DXCM) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free DXCM Stock Alerts $124.34 -13.67 (-9.91%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability DexCom Short Interest DataCurrent Short Volume11,770,000 sharesPrevious Short Volume14,570,000 sharesChange Vs. Previous Month-19.22%Dollar Volume Sold Short$1.58 billionShort Interest Ratio / Days to Cover3.9Last Record DateApril 15, 2024Outstanding Shares396,026,000 sharesPercentage of Shares Shorted2.97%Today's Trading Volume8,578,184 sharesAverage Trading Volume2,409,208 sharesToday's Volume Vs. Average356% Short Selling DexCom ? Sign up to receive the latest short interest report for DexCom and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDXCM Short Interest Over TimeDXCM Days to Cover Over TimeDXCM Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him DexCom Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,770,000 shares $1.58 billion -19.2%N/A3.9 $134.56 3/31/202414,570,000 shares $2.02 billion -8.2%N/A4.7 $138.70 3/15/202415,870,000 shares $2.07 billion -4.7%N/A5.3 $130.46 2/29/202416,650,000 shares $1.92 billion -2.5%N/A5.4 $115.07 2/15/202417,070,000 shares $2.01 billion -8.0%N/A5.7 $117.69 1/31/202418,560,000 shares $2.25 billion +1.8%N/A5.9 $121.35 Get the Latest News and Ratings for DXCM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DexCom and its competitors with MarketBeat's FREE daily newsletter. 1/15/202418,240,000 shares $2.28 billion -0.9%N/A5 $125.00 12/31/202318,410,000 shares $2.28 billion -2.9%N/A4.4 $124.09 12/15/202318,960,000 shares $2.32 billion -0.8%N/A4.1 $122.59 11/30/202319,120,000 shares $2.21 billion +7.7%N/A3.9 $115.52 11/15/202317,750,000 shares $1.81 billion -15.7%N/A3.4 $102.11 10/31/202321,060,000 shares $1.87 billion +30.7%N/A4.2 $88.83 10/15/202316,110,000 shares $1.23 billion +2.0%N/A3.5 $76.19 9/30/202315,800,000 shares $1.47 billion -1.4%N/A3.8 $93.30 9/15/202316,030,000 shares $1.54 billion -5.3%N/A4.4 $96.35 8/31/202316,920,000 shares $1.71 billion +0.8%N/A5 $100.98 8/15/202316,780,000 shares $1.92 billion +11.9%N/A5.4 $114.51 7/31/202315,000,000 shares $1.87 billion +21.2%N/A5.3 $124.56 7/15/202312,380,000 shares $1.70 billion -0.2%N/A4.7 $137.32 6/30/202312,410,000 shares $1.59 billion -2.4%N/A5 $128.51 6/15/202312,710,000 shares $1.66 billion -10.9%N/A5.3 $130.98 5/31/202314,260,000 shares $1.67 billion -1.4%N/A6.3 $117.26 5/15/202314,460,000 shares $1.73 billion +13.6%N/A6.5 $119.61 4/30/202312,730,000 shares $1.54 billion +5.4%N/A5.4 $121.34 4/15/202312,080,000 shares $1.40 billion -2.7%N/A5.3 $115.70 3/31/202312,410,000 shares $1.44 billion -1.4%N/A5.1 $116.18 3/15/202312,580,000 shares $1.43 billion -2.7%N/A5.1 $113.72 2/28/202312,930,000 shares $1.44 billion -2.0%N/A4.9 $111.01 2/15/202313,190,000 shares $1.59 billion +18.7%N/A5 $120.17 1/31/202311,110,000 shares $1.19 billion -5.6%N/A4.4 $107.09 1/15/202311,770,000 shares $1.28 billion +1.0%N/A4.3 $108.47 12/30/202211,650,000 shares $1.32 billion -7.0%N/A4.2 $113.24 12/15/202212,530,000 shares $1.46 billion -3.4%N/A4.3 $116.24 11/30/202212,970,000 shares $1.51 billion +3.0%N/A4.6 $116.28 11/15/202212,590,000 shares $1.46 billion +5.8%N/A4.5 $116.31 10/31/202211,900,000 shares $1.44 billion -13.1%N/A4.3 $120.78 10/15/202213,690,000 shares $1.33 billion +4.5%N/A4.8 $97.41 9/30/202213,100,000 shares $1.06 billion -14.1%N/A4.8 $80.54 9/15/202215,250,000 shares $1.39 billion +6.3%N/A5.9 $90.98 8/31/202214,350,000 shares $1.18 billion +7.2%N/A5.2 $82.21The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him DXCM Short Interest - Frequently Asked Questions What is DexCom's current short interest? Short interest is the volume of DexCom shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,770,000 shares of DXCM short. Learn More on DexCom's current short interest. What is a good short interest ratio for DexCom? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DXCM shares currently have a short interest ratio of 4.0. Learn More on DexCom's short interest ratio. Which institutional investors are shorting DexCom? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DexCom: Caas Capital Management LP, Portman Square Capital LLP, HBK Investments L P, Caas Capital Management LP, Citadel Advisors LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, IMC Chicago LLC, UBS Group AG, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Genus Capital Management Inc., and Valeo Financial Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is DexCom's short interest increasing or decreasing? DexCom saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 11,770,000 shares, a drop of 19.2% from the previous total of 14,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does DexCom's short interest compare to its competitors? Here is how the short interest of companies compare to DexCom: 3M (1.58%), ResMed Inc. (5.40%), Baxter International Inc. (1.91%), Insulet Co. (4.08%), Teleflex Incorporated (1.51%), NovoCure Limited (6.27%), Boston Scientific Co. (0.90%), West Pharmaceutical Services, Inc. (1.34%), Edwards Lifesciences Co. (1.25%), Cencora, Inc. (4.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short DexCom stock? Short selling DXCM is an investing strategy that aims to generate trading profit from DexCom as its price is falling. DXCM shares are trading down $13.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DexCom? A short squeeze for DexCom occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DXCM, which in turn drives the price of the stock up even further. How often is DexCom's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DXCM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 3M Short Squeeze ResMed Short Squeeze Baxter International Short Squeeze Insulet Short Squeeze Teleflex Short Squeeze NovoCure Short Squeeze Boston Scientific Short Squeeze West Pharmaceutical Services Short Squeeze Edwards Lifesciences Short Squeeze Cencora Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DXCM) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace